15,000 Shares in The Cigna Group (NYSE:CI) Purchased by HealthInvest Partners AB

HealthInvest Partners AB acquired a new position in shares of The Cigna Group (NYSE:CI - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,000 shares of the health services provider's stock, valued at approximately $4,492,000. The Cigna Group makes up about 3.5% of HealthInvest Partners AB's portfolio, making the stock its 13th largest position.

Several other hedge funds have also bought and sold shares of the business. Avestar Capital LLC increased its stake in The Cigna Group by 0.8% in the 3rd quarter. Avestar Capital LLC now owns 4,585 shares of the health services provider's stock worth $1,312,000 after buying an additional 35 shares during the period. Eads & Heald Wealth Management grew its holdings in The Cigna Group by 1.7% during the 3rd quarter. Eads & Heald Wealth Management now owns 2,123 shares of the health services provider's stock worth $607,000 after acquiring an additional 35 shares in the last quarter. Relyea Zuckerberg Hanson LLC grew its holdings in The Cigna Group by 3.2% during the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider's stock worth $333,000 after acquiring an additional 35 shares in the last quarter. Linscomb & Williams Inc. grew its holdings in The Cigna Group by 0.3% during the 4th quarter. Linscomb & Williams Inc. now owns 10,877 shares of the health services provider's stock worth $3,604,000 after acquiring an additional 36 shares in the last quarter. Finally, Wambolt & Associates LLC grew its holdings in The Cigna Group by 1.4% during the 2nd quarter. Wambolt & Associates LLC now owns 2,536 shares of the health services provider's stock worth $712,000 after acquiring an additional 36 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

The Cigna Group Trading Down 0.6 %

Shares of CI stock traded down $2.11 on Tuesday, hitting $346.79. 1,799,892 shares of the stock traded hands, compared to its average volume of 1,608,261. The firm's 50-day moving average price is $347.04 and its two-hundred day moving average price is $314.14. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.67 and a current ratio of 0.67. The stock has a market capitalization of $101.39 billion, a PE ratio of 20.06, a PEG ratio of 1.07 and a beta of 0.56. The Cigna Group has a twelve month low of $240.50 and a twelve month high of $365.71.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, beating the consensus estimate of $6.54 by $0.25. The firm had revenue of $51.15 billion for the quarter, compared to analysts' expectations of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The company's revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.96 EPS. As a group, analysts anticipate that The Cigna Group will post 28.36 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 21st. Investors of record on Wednesday, March 6th were issued a $1.40 dividend. This is a positive change from The Cigna Group's previous quarterly dividend of $1.23. This represents a $5.60 annualized dividend and a yield of 1.61%. The ex-dividend date was Tuesday, March 5th. The Cigna Group's payout ratio is 32.20%.

Insider Activity at The Cigna Group

In other The Cigna Group news, insider Eric P. Palmer sold 1,017 shares of the business's stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $335.26, for a total transaction of $340,959.42. Following the sale, the insider now directly owns 45,564 shares in the company, valued at $15,275,786.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the company's stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the sale, the senior vice president now directly owns 2,102 shares in the company, valued at $694,668.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Eric P. Palmer sold 1,017 shares of the company's stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $335.26, for a total transaction of $340,959.42. Following the sale, the insider now owns 45,564 shares in the company, valued at $15,275,786.64. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 114,144 shares of company stock worth $39,296,330. Company insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CI. Deutsche Bank Aktiengesellschaft upgraded shares of The Cigna Group from a "hold" rating to a "buy" rating and raised their price target for the company from $355.00 to $370.00 in a report on Thursday, February 1st. Wells Fargo & Company raised their price target on shares of The Cigna Group from $334.00 to $348.00 and gave the company an "equal weight" rating in a report on Tuesday, February 6th. Sanford C. Bernstein upgraded shares of The Cigna Group from a "market perform" rating to an "outperform" rating and raised their price target for the company from $330.00 to $372.00 in a report on Thursday, January 4th. Morgan Stanley reiterated an "overweight" rating and issued a $392.00 target price (up from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Finally, Royal Bank of Canada upgraded shares of The Cigna Group from a "sector perform" rating to an "outperform" rating and lifted their target price for the stock from $327.00 to $354.00 in a research note on Monday, February 5th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $362.14.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.